gsk liability, page-11

gsks lack of support for relenza had nothng to do with ease of administration of one drug versus another, it had to do with their misinterpretation of likely profits from this drug
tamiflu was not going anywhere two years ago either, until this bird flu pandemic hit, yet its use was supported, GSK is responsible for this difference and they will be liable.

Try telling an asthmatic not to bother with their ventolin next time they have an asthma attack cos its too hard to administer
also when the bird flu hits, just keep some tamiflu for yourself, and if there is only relenza because the H5 N1 has become resistant to tamiflu, than I would hope u dont go running to the docs for relenza because I am sure would surely have no idea how to adminster it to yourself !